Life sciences · Journal article
Angewandte Chemie · October 13, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT Metal–organic frameworks (MOFs) have emerged as promising nanophotosensitizers for photodynamic therapy (PDT), but most reported systems rely predominantly on a single O 2 ‐activation pathway, limiting their ability to produce complementary reactive oxygen species (ROS). Herein, we report a bifunctional MOF, Hf‐VIO‐DBP, that integrates porphyrinic photosensitizers (DBP) and viologen electron mediators (VIO 2+ ) within a single framework to establish a dual‐channel photoactive platform. The close spatial proximity of these two functional units enables efficient intra‐framework electron transfer while preserving the energy transfer capability of the porphyrinic photosensitizers. Upon 630 nm irradiation, excited DBP transfers electrons to VIO 2+ to generate viologen radical species, which mediate O 2 reduction to generate type I ROS, including superoxide, hydrogen peroxide, and hydroxyl radicals. The resulting DBP radical cation is reduced by endogenous biomolecules such as 1,4‐dihydronicotinamide adenine dinucleotide, thereby regenerating DBP and sustaining the photoredox cycle. Concurrently, energy transfer from excited DBP to O 2 produces singlet oxygen through a type II pathway. Compared with the viologen‐free MOF analogue, Hf‐VIO‐DBP markedly enhances type I ROS generation while retaining efficient type II ROS production, resulting in substantially improved overall ROS yields and phototoxicity. Therefore, Hf‐VIO‐DBP achieves potent PDT efficacy in CT26 and MC38 murine colon cancer models.